By: Sara Radcliffe CLSA President & CEO CLSA – California Life Sciences Association May 25, 2017 CLSA Board Goes to Washington to Meet with Members of Congress, Discuss Biomedical Innovation As advocacy is a core activity critical to our organization’s mission, I was honored to join 19 CLSA board members on Capitol Hill on May 3 for … Continue reading CLSA Board Visits Capitol Hill, Annual DC Spring Reception, CLSA Welcomes 14 New Members, Events in June, CLSA Board and Staff Continues Expansion
Read the latest in FAST and Fellows news: On April 27, BridgeBio Pharma announced the launch of Eidos Therapeutics, a CLSI 2016 FAST biopharmaceutical company developing a novel small-molecule treatment for transthyretin (TTR) amyloidosis. BridgeBio has committed $27 million and seasoned R&D executives to advance Eidos’ lead compound, AG10. AG10 was discovered and initially developed by Eidos’ co-founders Isabella Graef, … Continue reading FAST & Fellows Round-Up
By Paulo Rangel President & CEO of Evince Biosciences, Inc. Evince Biosciences is a next generation drug discovery company, using a compelling machine learning approach to reimagining drug discovery. Our first program targets toll-like receptor 7 (TLR7) for cancer immunotherapy. Simply stated, without a dramatic increase in R&D productivity, today’s pharmaceutical industry cannot sustain sufficient … Continue reading Combining an Unparalleled AI Platform with a Seasoned Pharma Team, Evince Biosciences Reimagines Drug Discovery and takes on Cancer Immunotherapy
The Festival of Genomics San Diego (June 26-27, 2017) will bring together the genomics community with the collaborative goal to drive the benefits of genomics to patients, faster. The Festival will provide the big picture of what is going on within the industry. If you’re using genomics to drive forward R&D, drug development or the … Continue reading Festival of Genomics San Diego
We are excited to announce that earlier this month several CLSA member companies, in conjunction with CLSA, CLSI and KNBR, launched the “Giants of Science” competition in San Francisco to award three $20,000 science program grants to Bay Area high schools who submit an application and video explaining why they need the grant and what … Continue reading CLSA Announces Bay Area “Giants of Sciences” Partnership with KNBR to Support Life Sciences Education
On May 3, 19 members of CLSA’s board of directors spent a full day on Capitol Hill meeting with more than two dozen key members of Congress on issues of importance to California’s life sciences innovation ecosystem.
On May 18, the House Energy & Commerce Health Subcommittee unanimously voted to advance legislation that would reauthorize the U.S. Food and Drug Administration’s (FDA) authority to collect user fees for another five years.
WASHINGTON & BAY AREA, May 9, 2017 – California Life Sciences Association (CLSA), the state’s premier public policy and business solutions organization representing the California life sciences industry, today commended the U.S. Senate’s confirmation of Scott Gottlieb, M.D., as the new commissioner of the U.S. Food and Drug Administration (FDA). As the key federal agency … Continue reading CLSA Applauds Confirmation of Dr. Scott Gottlieb as New FDA Commissioner
Taking a look beyond CLSA’s two most significant legislative battles of the year, Senate Bill 17 (Hernandez) and Assembly Bill 265 (Wood), CLSA notched a significant victory against opioid taxes, though the fight against state-level restrictions on physician payments has grown in intensity.
The California State Auditor’s office released a report on home-generated sharps and pharmaceutical waste disposal as directed by the Joint Legislative Audit Committee. The official request was to gather data on relevant laws and regulations, consumer education, current programs and their efficacy, best practices from other jurisdictions, volume of waste, and more.